hotspot -WSS

hotspot

author：leisure time 2025-09-28 15:06:51 - browse：11

glum Benjamin — health insurance coverage from STAT — Adobe

Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Walmart eyes Medicare Advantage provider ChenMed

hotspot

WSS

Childbirth

PEPFAR is under serious threat — and so is global health

Walmart eyes Medicare Advantage provider ChenMed

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Acelyrin, a rare IPO success, stumbles in its first big test

Latest bird flu infection made farmworker sicker than earlier cases

focus

hotspot

explore

How one medical school became remarkably diverse

WATCH: Why do bright lights make us see spots?

Activists slam private health insurers over coverage restrictions

IRA could hurt research into orphan drugs for rare diseases

Medicare details structure of new drug price negotiation program

Stigma and the return of syphilis

Bright Health sells Medicare Advantage business to Molina

PEPFAR is under serious threat — and so is global health

Jerome Adams on the need for new antivirals for Covid

Pig kidney works a record two months in donated body

entertainment

How medical schools plan to diversify without affirmative action

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

How to make the FDA’s new prescription one

FDA panel endorses Alnylam’s heart drug — after picking it apart

Long Covid needs a new name — and a new frame

FDA panel endorses Alnylam’s heart drug — after picking it apart

leisure time

Wikipedia

hotspot

Wikipedia